Aveanna Healthcare (NASDAQ:AVAH) Stock Crosses Above 50-Day Moving Average – Here’s Why

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH)’s share price passed above its 50-day moving average during trading on Thursday. The stock has a 50-day moving average of $13.10 and traded as high as $13.39. Aveanna Healthcare shares last traded at $13.26, with a volume of 2,326,589 shares.

Analyst Upgrades and Downgrades

A number of brokerages have commented on AVAH. Weiss Ratings raised shares of Aveanna Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, October 14th. Barclays lifted their price objective on shares of Aveanna Healthcare from $9.50 to $15.00 and gave the stock an “overweight” rating in a research report on Friday, August 28th. Wall Street Zen downgraded shares of Aveanna Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 15th. BMO Capital Markets increased their target price on Aveanna Healthcare from $10.00 to $14.00 and gave the company an “outperform” rating in a report on Friday, August 14th. Finally, Royal Bank Of Canada raised their price target on Aveanna Healthcare from $10.00 to $16.00 and gave the company an “outperform” rating in a research note on Monday, August 24th. One analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $14.25.

Aveanna Healthcare Price Performance

The company’s 50 day moving average is $13.10 and its 200 day moving average is $9.23. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 4.47. The stock has a market capitalization of $2.89 billion, a price-to-earnings ratio of 10.78, a price-to-earnings-growth ratio of 0.80 and a beta of 1.95.

Aveanna Healthcare (NASDAQ:AVAH) last released its quarterly earnings data on Thursday, August 13th. The company reported $0.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.17 by $0.05. The company had revenue of $670.48 million during the quarter, compared to the consensus estimate of $638.61 million. Aveanna Healthcare had a net margin of 10.56% and a return on equity of 80.70%. Research analysts anticipate that Aveanna Healthcare Holdings Inc. will post 0.77 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, major shareholder J.H. Whitney Equity Partners V sold 2,250,000 shares of the business’s stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $11.50, for a total value of $25,875,000.00. Following the completion of the sale, the insider directly owned 12,315,892 shares of the company’s stock, valued at approximately $141,632,758. The trade was a 15.45% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, major shareholder Robert Williams, Jr. sold 2,250,000 shares of Aveanna Healthcare stock in a transaction on Friday, August 21st. The shares were sold at an average price of $11.50, for a total transaction of $25,875,000.00. Following the completion of the transaction, the insider directly owned 12,315,892 shares in the company, valued at $141,632,758. The trade was a 15.45% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last three months, insiders sold 48,566,081 shares of company stock worth $558,509,932. Corporate insiders own 5.30% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the stock. BlackRock Inc. acquired a new stake in shares of Aveanna Healthcare during the 2nd quarter valued at $63,504,000. Braidwell LP increased its holdings in shares of Aveanna Healthcare by 39.1% in the 2nd quarter. Braidwell LP now owns 3,065,106 shares of the company’s stock valued at $26,268,000 after purchasing an additional 861,600 shares during the period. Dimensional Fund Advisors LP increased its stake in Aveanna Healthcare by 49.5% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,334,374 shares of the company’s stock valued at $8,593,000 after buying an additional 441,707 shares during the period. Hillsdale Investment Management Inc. lifted its position in Aveanna Healthcare by 4.3% in the 1st quarter. Hillsdale Investment Management Inc. now owns 927,030 shares of the company’s stock worth $5,970,000 after buying an additional 38,600 shares in the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. purchased a new stake in Aveanna Healthcare in the 2nd quarter worth approximately $7,881,000. Institutional investors and hedge funds own 87.96% of the company’s stock.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) is a provider of home-based healthcare services in the United States. The company serves patients across the lifespan, with a particular focus on children and adults who require ongoing medical support, skilled nursing or assistance with daily activities.

Aveanna’s services include private-duty nursing, home health care, hospice and palliative care, therapy, medical solutions and personal-care services. Its clinicians and caregivers support patients with complex medical conditions, disabilities and other needs in their homes and community settings, working with patients, families, physicians and healthcare organizations.

The company was established in 2016 through the combination of Pediatric Services of America and Epic Health Services and became a publicly traded company in 2021.